NIH Funding Opportunities (RSS Feed)

Rollout of Redesigned eRA Commons Home and Landing Screens in January 2021

November 25, 2020

Notice NOT-OD-21-028 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad)

November 25, 2020

Notice NOT-OD-21-035 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

November 24, 2020

Funding Opportunity PAR-21-084 from the NIH Guide for Grants and Contracts. The NIDCR Small Grant Program for New Investigators (R03) supports basic and clinical research conducted by scientists who are in the early stages of establishing an independent research career in oral, dental and craniofacial research. This program supports pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data for a subsequent investigator-initiated Research Project Grant (R01) or equivalent application.

For more information, visit the Sponsor URL.

Notice of Expiration of PAR-19-370 NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

November 24, 2020

Notice NOT-DE-20-034 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science

November 24, 2020

Notice NOT-OD-21-011 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

November 24, 2020

Funding Opportunity PAR-20-309 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age-related dementias using the Alzheimer's disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure.

For more information, visit the Sponsor URL.

Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications

November 24, 2020

Notice NOT-EB-20-017 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Notice of Clarification to NIEHS' Participation on PA-21-071, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"

November 24, 2020

Notice NOT-ES-21-004 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Notice of Intent to Publish a Funding Opportunity Announcement for Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed)

November 24, 2020

Notice NOT-EY-21-005 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

November 23, 2020

Funding Opportunity RFA-CA-21-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

For more information, visit the Sponsor URL.